Navidea Biopharmaceuticals to Present at the 11th Annual Needham Healthcare Conference
– Chief Business Officer to Provide Business and Development Program Updates –
DUBLIN, Ohio--(BUSINESS WIRE)-- Navidea Biopharmaceuticals, Inc. (NYSE Amex: NAVB) today announced that Dr. Thomas Tulip, Executive Vice President and Chief Business Officer, will participate at the 11th Annual Needham Healthcare Conference on April 3 - 4 at the New York Palace Hotel in New York City. Dr. Tulip will provide an update of the Company and its development programs on Tuesday April 3, 2012 at 10:00 AM EDT.
Investors and the public are invited to listen to a live webcast of Dr. Tulip’s presentation at http://wsw.com/webcast/needham51/navb/. Following the conference, the webcast will be archived for approximately 30 days.
About Navidea Biopharmaceuticals, Inc.
Navidea Biopharmaceuticals, Inc. (NYSE Amex: NAVB) is a biopharmaceutical company focused on the development and commercialization of precision diagnostics and radiopharmaceutical agents. Navidea is actively developing three radiopharmaceutical agent platforms – Lymphoseek®, AZD4694 and RIGScanTM – to help identify the sites and pathways of undetected disease and enable better diagnostic accuracy, clinical decision-making and ultimately patient care. Navidea’s strategy is to deliver superior growth and shareholder return by bringing to market novel radiopharmaceutical agents and advancing the Company’s pipeline through selective acquisitions, global partnering and commercialization efforts. For more information, please visit www.navidea.com.
Navidea Biopharmaceuticals
Brent Larson, (614) 822-2330
Sr.
VP & CFO
Source: Navidea Biopharmaceuticals, Inc.
Released March 29, 2012